Evaluation of hypophosphatemia: Lessons from patients with genetic disorders

American Journal of Kidney Diseases

Volumn 59, Issue 1, 2012, Pages 152-159

  Bacchetta, Justine ^a   Salusky, Isidro B ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Fibroblast growth factor 23 (FGF 23); hypophosphatemia; hypophosphatemic rickets; tumor induced osteomalacia

Indexed keywords

ALFACALCIDOL; ALKALINE PHOSPHATASE; FIBROBLAST GROWTH FACTOR 23; PHOSPHATE;

ADULT; ARTICLE; BONE MALFORMATION; CASE REPORT; FEMALE; FOLLOW UP; GENETIC DISORDER; HUMAN; HYPOPHOSPHATEMIA; PHOSPHATE METABOLISM;

ADULT; FEMALE; HUMANS; HYPOPHOSPHATEMIA;

EID: 83655201226     PISSN: 02726386     EISSN: 15236838     Source Type: Journal    
DOI: 10.1053/j.ajkd.2011.08.035     Document Type: Article

References (43)

1. N.C. Bugg, J.A. Jones Hypophosphataemia Pathophysiology, effects and management on the intensive care unit Anaesthesia 53 1998 895 902
2. M. Ruppe, S.M. Jan de Beur Disorders of phosphate homeostasis C.J. Rosen, Primer on the Metabolic Bone Diseases and Disorders of Mineral Metabolism 7th ed. 2008 American Society for Bone and Mineral Research Washington, DC 317 324
3. L. Ardeshirpour, D.E. Cole, T.O. Carpenter Evaluation of bone and mineral disorders Pediatr Endocrinol Rev 5 suppl 1 2007 584 598
4. H. Hruska Hyperphosphatemia and hypophosphatemia M. Favus, Primer on the Metabolic Bone Diseases and Disorders of Mineral Metabolism 6th ed. 2006 American Society for Bone and Mineral Research Washington, DC 233 242
5. ADHR Consortium Autosomal dominant hypophosphataemic rickets is associated with mutations in FGF23 Nat Genet 26 2000 345 348
6. T. Shimada, S. Mizutani, T. Muto Cloning and characterization of FGF23 as a causative factor of tumor-induced osteomalacia Proc Natl Acad Sci U S A 98 2001 6500 6505
7. H.Y. Cho, B.H. Lee, J.H. Kang, I.S. Ha, H.I. Cheong, Y. Choi A clinical and molecular genetic study of hypophosphatemic rickets in children Pediatr Res 58 2005 329 333
8. H. Olauson, A.R. Qureshi, T. Miyamoto Relation between serum fibroblast growth factor-23 level and mortality in incident dialysis patients: are gender and cardiovascular disease confounding the relationship? Nephrol Dial Transplant 25 2010 3033 3038
9. R. Subramanian, R. Khardori Severe hypophosphatemia Pathophysiologic implications, clinical presentations, and treatment Medicine (Baltimore) 79 2000 1 8
10. Y. Shimizu, Y. Tada, M. Yamauchi Hypophosphatemia induced by intravenous administration of saccharated ferric oxide: another form of FGF23-related hypophosphatemia Bone 45 2009 814 816
11. C.I. Bagnis, S. Karie, G. Deray, M. Essig Hypophosphataemia: an easy strategy for diagnosis and treatment in HIV patients Antivir Ther 14 2009 481 488
12. S. Kerr, J. Kindt, S.R. Daram Hypophosphatemia associated with paraproteinemia: a case report and review of the literature WMJ 106 2007 490 493
13. J. Amanzadeh, R.F. Reilly Jr Hypophosphatemia: an evidence-based approach to its clinical consequences and management Nat Clin Pract Nephrol 2 2006 136 148
14. J.H. Barth, R.G. Jones, R.B. Payne Calculation of renal tubular reabsorption of phosphate: the algorithm performs better than the nomogram Ann Clin Biochem 37 pt 1 2000 79 81
15. B. Guyton, J. Hall Textbook of Medical Physiology 11th ed. 2006 Elsevier Saunders Philadelphia, PA
16. A.A. Portale, B.P. Halloran, R.C. Morris Jr Dietary intake of phosphorus modulates the circadian rhythm in serum concentration of phosphorus Implications for the renal production of 1,25-dihydroxyvitamin D J Clin Invest 80 1987 1147 1154
17. T. Shimada, I. Urakawa, T. Isakova Circulating fibroblast growth factor 23 in patients with end-stage renal disease treated by peritoneal dialysis is intact and biologically active J Clin Endocrinol Metab 95 2010 578 585
18. J. Bacchetta, P. Cochat, I.B. Salusky FGF23 et klotho: les nouveaux incontournables du métabolisme phosphocalcique Arch Pédiatr 18 6 2011 686 695
19. M.S. Razzaque FGF23-mediated regulation of systemic phosphate homeostasis: is klotho an essential player? Am J Physiol Renal Physiol 296 2009 F470 F476
20. D. Prie, P. Urena Torres, G. Friedlander Latest findings in phosphate homeostasis Kidney Int 75 2009 882 889
21. J. Gattineni, M. Baum Regulation of phosphate transport by fibroblast growth factor 23 (FGF23): implications for disorders of phosphate metabolism Pediatr Nephrol 25 2010 591 601
22. B. Lorenz-Depiereux, D. Schnabel, D. Tiosano, G. Hausler, T.M. Strom Loss-of-function ENPP1 mutations cause both generalized arterial calcification of infancy and autosomal-recessive hypophosphatemic rickets Am J Hum Genet 86 2010 267 272
23. Y. Yamazaki, T. Tamada, N. Kasai Anti-FGF23 neutralizing antibodies show the physiological role and structural features of FGF23 J Bone Miner Res 23 2008 1509 1518
24. J. Bacchetta, L. Dubourg, J. Harambat The influence of glomerular filtration rate and age on fibroblast growth factor 23 serum levels in pediatric chronic kidney disease J Clin Endocrinol Metab 95 2010 1741 1748
25. H. Kurosu, O.M. Kuro The klotho gene family as a regulator of endocrine fibroblast growth factors Mol Cell Endocrinol 299 2009 72 78
26. E.G. Farrow, S.I. Davis, L.J. Summers, K.E. White Initial FGF23-mediated signaling occurs in the distal convoluted tubule J Am Soc Nephrol 20 2009 955 960
27. M.C. Hu, M. Shi, J. Zhang Klotho: a novel phosphaturic substance acting as an autocrine enzyme in the renal proximal tubule FASEB J 24 2010 3438 3450
28. Q. Chang, S. Hoefs, A.W. van der Kemp, C.N. Topala, R.J. Bindels, J.G. Hoenderop The beta-glucuronidase klotho hydrolyzes and activates the TRPV5 channel Science 310 2005 490 493
29. S.M. Burnett, S.C. Gunawardene, F.R. Bringhurst, H. Juppner, H. Lee, J.S. Finkelstein Regulation of C-terminal and intact FGF-23 by dietary phosphate in men and women J Bone Miner Res 21 2006 1187 1196
30. T. Kawata, Y. Imanishi, K. Kobayashi Parathyroid hormone regulates fibroblast growth factor-23 in a mouse model of primary hyperparathyroidism J Am Soc Nephrol 18 2007 2683 2688
31. D.G. Shirley, N.J. Faria, R.J. Unwin, H. Dobbie Direct micropuncture evidence that matrix extracellular phosphoglycoprotein inhibits proximal tubular phosphate reabsorption Nephrol Dial Transplant 25 2010 3191 3195
32. H. Wang, Y. Yoshiko, R. Yamamoto Overexpression of fibroblast growth factor 23 suppresses osteoblast differentiation and matrix mineralization in vitro J Bone Miner Res 23 2008 939 948
33. K. Wesseling-Perry, R.C. Pereira, H. Wang Relationship between plasma fibroblast growth factor-23 concentration and bone mineralization in children with renal failure on peritoneal dialysis J Clin Endocrinol Metab 94 2009 511 517
34. R.C. Pereira, H. Juppner, C.E. Azucena-Serrano, O. Yadin, I.B. Salusky, K. Wesseling-Perry Patterns of FGF-23, DMP1, and MEPE expression in patients with chronic kidney disease Bone 45 2009 1161 1168
35. E.A. Imel, L.A. DiMeglio, S.L. Hui, T.O. Carpenter, M.J. Econs Treatment of X-linked hypophosphatemia with calcitriol and phosphate increases circulating fibroblast growth factor 23 concentrations J Clin Endocrinol Metab 95 2010 1846 1850
36. T.O. Carpenter, E.A. Imel, I.A. Holm, S.M. Jan de Beur, K.L. Insogna A clinician's guide to X-linked hypophosphatemia J Bone Miner Res 26 2011 1381 1388
37. J. Bacchetta Rachitisme hypophosphatémique P. Cochat, Progrs en Pédiatrie, Néphrologie Pédiatrique 2011 Doin Rueil-Malmaison, France
38. M. Reyes-Mugica, S.L. Arnsmeier, P.F. Backeljauw, J. Persing, B. Ellis, T.O. Carpenter Phosphaturic mesenchymal tumor-induced rickets Pediatr Dev Pathol 3 2000 61 69
39. V.L. Woo, R. Landesberg, E.A. Imel Phosphaturic mesenchymal tumor, mixed connective tissue variant, of the mandible: report of a case and review of the literature Oral Surg Oral Med Oral Pathol Oral Radiol Endod 108 2009 925 932
40. H. Raeder, N. Shaw, C. Netelenbos, R. Bjerknes A case of X-linked hypophosphatemic rickets: complications and the therapeutic use of cinacalcet Eur J Endocrinol 159 suppl 1 2008 S101 S105
41. U.S. Alon, R. Levy-Olomucki, W.V. Moore, J. Stubbs, S. Liu, L.D. Quarles Calcimimetics as an adjuvant treatment for familial hypophosphatemic rickets Clin J Am Soc Nephrol 3 2008 658 664
42. Y. Aono, Y. Yamazaki, J. Yasutake Therapeutic effects of anti-FGF23 antibodies in hypophosphatemic rickets/osteomalacia J Bone Miner Res 24 2009 1879 1888
43. I. Holm, M. Econs, T. Carpenter Familial hypophosphatemia and related disorders F.H. Glorieux, Pediatric Bone, Biology and Diseases 2003 Elsevier San Diego, CA 603 631